| View |
|
DR-XY22030
|
Eperisone Hydrochloride
|
Myonal
|
50mg
|
Tablet
|
-
|
Swiss Pharma Research Laboratories, Inc.
|
Philippines
|
-
|
05 February 2021
|
14 October 2026
|
| View |
|
DR-XY22082
|
Bromhexine Hydrochloride
|
None
|
4mg/ 5mL
|
Syrup
|
Mucolytic
|
Fortis Medi Pharmaceutical, Inc.
|
Philippines
|
Automatic Renewal
|
16 March 2023
|
19 March 2028
|
| View |
|
DR-XY22116
|
Metronidazole
|
Rodazid
|
125 mg/5 mL
|
Suspension
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
06 October 2020
|
30 April 2025
|
| View |
|
DR-XY22121-B
|
Cefalexin (As Monohydrate)
|
Cefax
|
100 mg/mL
|
Powder For Oral Suspension (Oral Drops)
|
Antibacterials (Cephalosporins)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 November 2022
|
13 October 2027
|
| View |
|
DR-XY22130
|
Carvedilol
|
Dilatrend
|
25 mg
|
Tablet
|
ALPHA AND BETA ADRENOCEPTOR BLOCKER
|
Roche S.p.A.
|
Italy
|
Automatic Renewal
|
19 May 2023
|
26 October 2028
|
| View |
|
DR-XY22152-B
|
Paracetamol
|
Termagen
|
250 mg/5 mL
|
Syrup
|
Analgesic/Antipyretic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
20 June 2022
|
22 August 2027
|
| View |
|
DR-XY22259
|
Allopurinol
|
Alpurin
|
300 mg
|
Tablet
|
Antigout preparation (Preparation inhibiting uric acid production)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
06 October 2022
|
21 November 2027
|
| View |
|
DR-XY22291
|
Dicycloverine (As Hydrochloride)
|
Zyclodex
|
10 mg
|
Tablet
|
Anticholinergic
|
Lloyd Laboratores, Inc.
|
Philippines
|
Automatic Renewal
|
12 April 2022
|
02 December 2027
|
| View |
|
DR-XY22319
|
Cotrimazine
|
None
|
205 mg/ 45 mg per 5 mL
|
Suspension
|
Antibacterial
|
Drugmakers Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
29 May 2023
|
13 June 2028
|
| View |
|
DR-XY22326
|
Sulodexide
|
Vessel Due F
|
300 LSU/mL
|
Solution For Injection
|
Antithrombotic Agent
|
Alfa Sigma S.p.A.
|
Italy
|
Renewal
|
19 April 2024
|
19 June 2029
|
| View |
|
DR-XY22369
|
Adapalene
|
Differin
|
0.1% (1mg/g)
|
Gel
|
Anti-Acne Gel
|
Laboratories Galderma
|
France
|
Automatic Renewal
|
07 December 2021
|
29 January 2027
|
| View |
|
DR-XY22421
|
Cefalexin (as Monohydrate)
|
Xinflex
|
100mg/ mL
|
Oral Drops
|
Antibacterial (Cephalosporin)
|
Drugmakers Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 December 2021
|
09 January 2027
|
| View |
|
DR-XY22428
|
Dextrose Hydrous + Electrolytes
(see reverse for complete formulation)
|
Dianeal PD-4 Low Calcium w/4.25% Peritoneal Dialysis Solution
|
Formulation: Each 100 mL contains:
Dextrose hydrous-4.25 g Sodium Chloride-538 mg Sodium Lactate-448 mg
Calcium Chloride-18.3 mg Magnesium Chloride-5.08 mg
|
Solution for Injection (Intraperitoneal)
|
Peritoneal Dialysis Solution
|
Baxter Healthcare Philippines Inc.
|
Philippines
|
Automatic Renewal
|
17 March 2023
|
07 March 2028
|
| View |
|
DR-XY22431
|
Salbutamol (as Sulfate)
|
Efamed
|
2mg/ 5mL
|
Syrup
|
Antiasthma
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
27 December 2021
|
16 January 2027
|
| View |
|
DR-XY22434
|
Peritoneal Dialysis Solution Low Calcium with 1.5 % Dextrose
|
Dianeal Pd-4 Low Calcium with 1.5 % Dextrose
|
Each 100 mL contains: Dextrose Hydrous 1.5 g Sodium Chloride 538 mg Sodium Lactate 448 mg Calcium Chloride Dihydrate 18.3 mg Magnesium Chloride Hexahydrate 5.08 mg
|
Solution for Intraperitoneal Administration
|
Peritoneal Dialysis Solution
|
Baxter Healthcare Philippines Inc.
|
Philippines
|
Automatic Renewal
|
17 March 2023
|
07 March 2028
|
| View |
|
DR-XY22482
|
Iron
|
Beefer Plus
|
44mg/5mL
|
Syrup
|
Hematinic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
24 December 2021
|
22 January 2027
|
| View |
|
DR-XY22507
|
Cefalexin (As Monohydrate)
|
Celoxone
|
250 mg/5 mL
|
Powder for Suspension
|
-
|
LLOYD LABORATORIES, INC.
|
Philippines
|
-
|
01 December 2020
|
24 January 2026
|
| View |
|
DR-XY22512
|
Voglibose
|
Basen
|
200mcg
|
Tablet
|
-
|
Takeda Pharmaceutical Company Limited (Osaka Plant)
|
Japan
|
-
|
29 December 2020
|
14 December 2025
|
| View |
|
DR-XY22513
|
Voglibose
|
Basen
|
300mcg
|
Tablet
|
-
|
Takeda Pharmaceutical Company Limited (Osaka Plant)
|
Japan
|
-
|
29 December 2020
|
14 December 2025
|
| View |
|
DR-XY22538
|
Dextrose Hydrous + Electrolytes
(see reverse for complete formulation)
|
Dianeal PD-4 Low Calcium w/2.5% Peritoneal Dialysis Solution
|
Formulation: Each 100 mL contains:
Dextrose hydrous-4.25 g Sodium Chloride-538 mg Sodium Lactate-448 mg
Calcium Chloride-18.3 mg Magnesium Chloride-5.08 mg
|
Solution for Injection (Intraperitoneal)
|
Peritoneal Dialysis Solution
|
Baxter Healthcare Philippines Inc.
|
Philippines
|
Automatic Renewal
|
17 February 2023
|
07 March 2028
|